• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 14, 2022 at 11:02: AM
via The Food and Drug Administration has approved AstraZeneca and Merck & Co.'s drug Lynparza for people with a genetic form of early breast cancer, a decision that could spur greater use of DNA testing in diagnosing and treating the disease.

article source
 




Top Bottom
Back
Quote